Skip to main content

Military Health System

COVID-19 Booster Effectiveness Remained High During Omicron Surge

Image of Hospital Corpsman 1st Class Mary Ashcraft, assigned to the combat ship USS Tulsa, administers a COVID-19 vaccine booster to Aviation Machinist Mate 1st Class Anthony Johnson Jan. 10, 2022, at Apra Harbor, Guam. (Photo: Mass Communication Specialist Petty Officer 1st Class Devin M. Langer, Command Destroyer Squadron 7). Hospital Corpsman 1st Class Mary Ashcraft, assigned to the combat ship USS Tulsa, administers a COVID-19 vaccine booster to Aviation Machinist Mate 1st Class Anthony Johnson Jan. 10, 2022, at Apra Harbor, Guam. (Photo: Mass Communication Specialist Petty Officer 1st Class Devin M. Langer, Command Destroyer Squadron 7)

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

Active-duty service members who received a COVID-19 vaccine booster shot were significantly less likely to be infected and show symptoms of the disease during the surge of the Omicron variant this winter, according to a recent study. 

The study highlights the effectiveness of booster shots, which were first formally recommended by the Centers for Disease Control and Prevention in November. 

“The findings support the policy of booster doses at five months after the primary series and show improved vaccine effectiveness with a booster dose even during times of a newly emerging SARS-CoV-2 variant,” said Shauna Stahlman. She is a senior epidemiologist in the Epidemiology and Analysis Branch of the Armed Forces Health Surveillance Division

But a separate study also found that the number of active-duty service members who were voluntarily getting booster shots lagged behind the general U.S. population. 

As of Jan. 31, only 24% of active-duty service members who were eligible for a booster had voluntarily received the additional shot, according to Army Col. (Dr.) James Mancuso. Mancuso chairs the Preventive Medicine and Biostatistics Department at the Uniformed Services University of Health Sciences’ Hebert School of Medicine. His group led the booster uptake study in collaboration with Stahlman and AFHSD. 

By comparison, in the general U.S. population as of Feb. 10, about 46.8% of the booster-eligible population had received the additional shot. “This is likely reflective of [active-duty service members] being a relatively younger and healthier population,” Stahlman said. 

The study found that service members were less likely to get a booster shot if they were younger, lower in rank or had lower education levels. Similar studies of the civilian population show that younger and healthier people have been less likely to seek out vaccines and booster shots. 

Overall, the rate at which service members sought out and received booster shots increased during the surge of infections linked to the Omicron variant beginning in December 2021. Vaccine uptake among active-duty service members also went up in November 2021 after the CDC recommended that all adults get a booster, Stahlman noted. 

The Pentagon mandated initial COVID-19 vaccinations for service members in August 2021. However, booster shots remain voluntary. 

Booster Mandate Coming? 

Stahlman said the study’s findings suggest that “high levels of booster uptake among [active-duty service members] are unlikely to be accomplished on a voluntary basis.” 

In mid-December, the Pentagon said there were “active discussions” within the DOD about making the booster shots mandatory for service members. The Defense Department has not issued any requirement for a booster because the booster doses are only used under emergency authorization. The primary vaccination series (e.g., generally the first two shots) are fully approved by the Food and Drug Administration. 

Mancuso said that currently, the best way to promote booster vaccination is to encourage service members to discuss their own personal risks of COVID-19 and benefits from getting the booster shot with their primary unit-level health care providers.  

“These providers should be encouraging vaccination due to its benefits to the health of the individual as well as to military readiness and overall the health of the force.” 

FDA’s vaccine advisory committee met April 6 on questions about booster doses. The CDC has not yet scheduled a meeting on the subject of boosters with its advisory group on vaccines. 

Who Didn’t Get Boosted 

The study found that active-duty service members were less likely to get a booster shot if they had a previous COVID-19 infection. Active-duty service members in the U.S. received fewer boosters compared to those stationed overseas. 

Other factors that appeared to result in lower booster uptake were being male and serving in the Marine Corps. 

The study did not find any significant differences in booster shot uptake among different races and ethnicities, as was seen in a previous study of the primary vaccination series. 

Booster Vaccine Effectiveness 

Vaccine effectiveness “was significantly higher” among service members who received a booster shot compared to those who only received the initial vaccination, regardless of the month or time since their primary vaccination, Stahlman said. 

Even during the surge, service members who received a booster shot had 43% to 63% reduced odds of developing symptomatic COVID-19 when compared to those who were vaccinated with the primary series but didn’t receive the booster, according to the study. 

“Our patterns of vaccine effectiveness estimates are generally similar to those observed in the U.S. population and among military veterans,” she added. 

The booster vaccine effectiveness study reviewed military vaccination data for active-duty service members who were tested for SARS-CoV-2 between July 2021 and January 2022. The study evaluated the three existing vaccines from Pfizer/BioNTech, Moderna, and Johnson & Johnson/Janssen. 

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: April 18, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery